Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | sirtuin 1 | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | 0.0034 | 0.0117 | 0.0117 |
Loa Loa (eye worm) | hypothetical protein | 0.0095 | 0.0861 | 0.0861 |
Schistosoma mansoni | plexin | 0.0034 | 0.0117 | 0.0759 |
Loa Loa (eye worm) | hypothetical protein | 0.0095 | 0.0861 | 0.0861 |
Loa Loa (eye worm) | hypothetical protein | 0.0131 | 0.1294 | 0.1294 |
Brugia malayi | Protein kinase domain containing protein | 0.0803 | 0.9445 | 0.9445 |
Loa Loa (eye worm) | hypothetical protein | 0.0701 | 0.8206 | 0.8206 |
Onchocerca volvulus | 0.0095 | 0.0861 | 1 | |
Schistosoma mansoni | chromatin regulatory protein sir2 | 0.0151 | 0.1535 | 1 |
Leishmania major | protein kinase, putative | 0.0849 | 1 | 0.5 |
Echinococcus multilocularis | NAD dependent deacetylase sirtuin 1 | 0.0151 | 0.1535 | 0.1535 |
Onchocerca volvulus | 0.0095 | 0.0861 | 1 | |
Echinococcus multilocularis | plexin a4 | 0.0069 | 0.0543 | 0.0543 |
Onchocerca volvulus | 0.0058 | 0.0413 | 0.4799 | |
Echinococcus granulosus | plexin a4 | 0.0069 | 0.0543 | 0.0543 |
Trypanosoma brucei | protein kinase, putative | 0.0849 | 1 | 0.5 |
Trichomonas vaginalis | chromatin regulatory protein sir2, putative | 0.0151 | 0.1535 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0095 | 0.0861 | 0.5606 |
Loa Loa (eye worm) | TK/ALK protein kinase | 0.0802 | 0.9441 | 0.9441 |
Echinococcus granulosus | MAM | 0.0095 | 0.0861 | 0.0861 |
Echinococcus granulosus | NAD dependent deacetylase sirtuin 1 | 0.0151 | 0.1535 | 0.1535 |
Loa Loa (eye worm) | hypothetical protein | 0.0095 | 0.0861 | 0.0861 |
Echinococcus multilocularis | eukaryotic translation initiation factor 2 alpha | 0.0849 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0058 | 0.0413 | 0.0413 |
Giardia lamblia | NAD-dependent histone deacetylase Sir2 | 0.0151 | 0.1535 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0034 | 0.0117 | 0.0759 |
Brugia malayi | plexin A | 0.0069 | 0.0543 | 0.0543 |
Loa Loa (eye worm) | hypothetical protein | 0.0151 | 0.1535 | 0.1535 |
Schistosoma mansoni | hypothetical protein | 0.0095 | 0.0861 | 0.5606 |
Trypanosoma brucei | eukaryotic translation initiation factor 2-alpha kinase 1, putative | 0.0849 | 1 | 0.5 |
Trichomonas vaginalis | chromatin regulatory protein sir2, putative | 0.0151 | 0.1535 | 0.5 |
Trichomonas vaginalis | chromatin regulatory protein sir2, putative | 0.0151 | 0.1535 | 0.5 |
Schistosoma mansoni | plexin | 0.0058 | 0.0413 | 0.269 |
Loa Loa (eye worm) | plexin A | 0.0069 | 0.0543 | 0.0543 |
Entamoeba histolytica | protein kinase domain containing protein | 0.0849 | 1 | 0.5 |
Echinococcus multilocularis | MAM | 0.0095 | 0.0861 | 0.0861 |
Entamoeba histolytica | protein kinase domain containing protein | 0.0849 | 1 | 0.5 |
Trichomonas vaginalis | chromatin regulatory protein sir2, putative | 0.0151 | 0.1535 | 0.5 |
Brugia malayi | hypothetical protein | 0.0095 | 0.0861 | 0.0861 |
Loa Loa (eye worm) | PEK/HRI protein kinase | 0.0849 | 1 | 1 |
Brugia malayi | NAD-dependent deacetylase SIRT1 | 0.0151 | 0.1535 | 0.1535 |
Brugia malayi | Plexin repeat family protein | 0.0058 | 0.0413 | 0.0413 |
Echinococcus granulosus | eukaryotic translation initiation factor 2 alpha | 0.0849 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 4.5 uM | Inhibition of recombinant SIRT1 preincubated for 5 mins before addition of substrate measured after 1 hr by fluorescence-based assay | ChEMBL. | 19296597 |
IC50 (binding) | = 83.4 uM | Inhibition of recombinant SIRT2 preincubated for 5 mins before addition of substrate measured after 3 hrs by fluorescence-based assay | ChEMBL. | 19296597 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.